Pages that link to "Q41637237"
Jump to navigation
Jump to search
The following pages link to Lovastatin inhibits low-density lipoprotein oxidation and alters its fluidity and uptake by macrophages: in vitro and in vivo studies (Q41637237):
Displaying 50 items.
- Statins for women with polycystic ovary syndrome not actively trying to conceive (Q24234599) (← links)
- Statins for women with polycystic ovary syndrome not actively trying to conceive (Q24236132) (← links)
- Effects of statins on progression of carotid atherosclerosis as measured by carotid intimal--medial thickness: a meta-analysis of randomized controlled trials (Q33578968) (← links)
- Statins in the treatment of polycystic ovary syndrome (Q33789151) (← links)
- The evolving role of statins in the management of atherosclerosis (Q33818141) (← links)
- New insights into the pharmacodynamic and pharmacokinetic properties of statins. (Q33832848) (← links)
- Non-lipid-related effects of statins (Q33924588) (← links)
- Beneficial effects of statins in coronary artery disease--beyond lowering cholesterol (Q34122524) (← links)
- Going from immutable to mutable atherosclerotic plaques (Q34345249) (← links)
- Pravastatin inhibits cellular cholesterol synthesis and increases low density lipoprotein receptor activity in macrophages: in vitro and in vivo studies (Q34346720) (← links)
- Statins, the renin-angiotensin-aldosterone system and hypertension - a tale of another beneficial effect of statins. (Q34429685) (← links)
- LDL oxidation by arterial wall macrophages depends on the oxidative status in the lipoprotein and in the cells: role of prooxidants vs. antioxidants (Q34480726) (← links)
- Antiinflammatory and immunomodulatory properties of statins (Q34644504) (← links)
- Pharmacology of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors (statins), including rosuvastatin and pitavastatin (Q34773911) (← links)
- Effects of statins on the vasculature: Implications for aggressive lipid management in the cardiovascular metabolic syndrome (Q35077217) (← links)
- Thinking Intelligently About Therapy of Atherosclerosis (Q35587360) (← links)
- Lipoprotein composition and oxidative modification during therapy with gemfibrozil and lovastatin in patients with combined hyperlipidaemia. (Q35802180) (← links)
- HMG-CoA reductase inhibitors: do they have potential in the treatment of polycystic ovary syndrome? (Q37253000) (← links)
- Molecular structure of low density lipoprotein: current status and future challenges (Q37271722) (← links)
- New approaches to the prevention of atherosclerosis (Q40923118) (← links)
- Atorvastatin and gemfibrozil metabolites, but not the parent drugs, are potent antioxidants against lipoprotein oxidation (Q41019483) (← links)
- Review of progress in sterol oxidations: 1987-1995. (Q41051532) (← links)
- Decreased susceptibility to copper-induced oxidation of rat-lipoproteins after fibrate treatment: influence of fatty acid composition. (Q41968921) (← links)
- Simvastatin treatment prevents oxidative damage to DNA in whole blood leukocytes of dyslipidemic type 2 diabetic patients (Q43000203) (← links)
- Statins and modulation of oxidative stress. (Q43215640) (← links)
- Examination of pineal indoles and 6-methoxy-2-benzoxazolinone for antioxidant and antimicrobial effects (Q43794332) (← links)
- Pravastatin suppress superoxide and fibronectin production of glomerular mesangial cells induced by oxidized-LDL and high glucose (Q43833289) (← links)
- Gemfibrozil lowers plasma lipids and increases polyunsaturated fatty acid content and oxidative susceptibility of lipoproteins in hypertriglyceridemia (Q44053509) (← links)
- Neuroprotective effects of statins may not be related to total and low-density lipoprotein cholesterol lowering (Q44228337) (← links)
- Beneficial effects of fluvastatin on progressive renal allograft dysfunction (Q44491073) (← links)
- A comparative study of the in vitro antioxidant activity of statins (Q44575041) (← links)
- Effects of Atorvastatin on LDL sub-fractions and peroxidation in type 1 diabetic patients: a randomised double-blind placebo-controlled study (Q44675894) (← links)
- Atorvastatin effect on high-density lipoprotein-associated paraoxonase activity and oxidative DNA damage (Q45111292) (← links)
- Effects of simvastatin on blood lipids, vitamin E, coenzyme Q10 levels and left ventricular function in humans (Q46427233) (← links)
- Reduced susceptibility of low density lipoprotein to lipid peroxidation after cholestyramine treatment in heterozygous familial hypercholesterolemic children (Q51547861) (← links)
- Simvastatin Therapy Reduces Prooxidant‐Antioxidant Balance: Results of a Placebo‐Controlled Cross‐Over Trial (Q57892563) (← links)
- The effect of simvastatin treatment on natural antioxidants in low-density lipoproteins and high-energy phosphates and ubiquinone in skeletal muscle (Q71063989) (← links)
- Effect of low-dose simvastatin on cholesterol levels, oxidative susceptibility, and antioxidant levels of low-density lipoproteins in patients with hypercholesterolemia: a pilot study (Q71806069) (← links)
- Pathogenesis of atherosclerosisand the role of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors (Q71857110) (← links)
- Renal hemodynamic effects of lovastatin in a renal ablation model (Q71917562) (← links)
- Interactions of MDL 29,311 and probucol metabolites with cholesteryl esters (Q72540628) (← links)
- Reduced susceptibility of low density lipoprotein (LDL) to lipid peroxidation after fluvastatin therapy is associated with the hypocholesterolemic effect of the drug and its binding to the LDL (Q73112077) (← links)
- HMG CoA reductase inhibitors are related to improved systemic endothelial function in coronary artery disease (Q73176738) (← links)
- Pravastatin down-regulates inflammatory mediators in human monocytes in vitro (Q73337591) (← links)
- Melatonin inhibits oxidative modification of human low‐density lipoprotein (Q73564715) (← links)
- Preservation of Endogenous Antioxidant Activity and Inhibition of Lipid Peroxidation as Common Mechanisms of Antiatherosclerotic Effects of Vitamin E, Lovastatin and Amlodipine (Q73565510) (← links)
- HMG-CoA reductase inhibitors suppress macrophage growth induced by oxidized low density lipoprotein (Q73589906) (← links)
- Plasma LDL Oxidation Leads to Its Aggregation in the Atherosclerotic Apolipoprotein E-Deficient Mice (Q73965908) (← links)
- Interactions of Platelets, Macrophages, and Lipoproteins in Hypercholesterolemia: Antiatherogenic Effects of HMG-CoA Reductase Inhibitor Therapy (Q74144126) (← links)
- Simvastatin decreases aldehyde production derived from lipoprotein oxidation (Q77220461) (← links)